EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Genomics and Precision Medicine: Exploring the Role of Genomics in Identifying Genetic Markers for Disease Susceptibility and Treatment Response
The advent of genomics has ushered in a new era of healthcare characterized by a paradigm shift from onesizefitsall medicine to precision medicine This transformative approach leverages the power of genetic information to tailor medical interventions to individual patients optimizing treatment efficacy and minimizing adverse effects
Market Access Strategies for Pharma Products in Europe: A Comprehensive Guide
The European pharmaceutical market is dynamic and diverse presenting both opportunities and challenges for companies seeking market access This guide delves into effective strategies for navigating the complexities of market access in Europe focusing on key aspects such as reimbursement pricing and overcoming market entry challenges
Robotic Process Automation: The Catalyst for Pharma 4.0 Evolution
The pharmaceutical industry is experiencing a massive shift to new era phase known as Industry or less commonly known as Pharma in this context In the middle of this transformational journey we have Robotic Process Automation RPA as a tool that is disruptive in the way these pharmaceutical organizations are run and managed
Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026
Pharmaceutical business is moving into a decisive decade in which ethical sourcing has ceased being a corporate value of goodwill and has become a strategic need Pharma ethical sourcing is closely connected to business continuity regulatory compliance environmental stewardship and brand trust in With supply chains that are increasingly global fragmented and vulnerable to geopolitical climatic and...
Understanding Pharmacodynamics: The Science behind Drug Action Mechanisms
In the complicated world of pharmacology pharmacodynamics is also a place that is a bridge between chemistry and physiology Drugs do something somewhere and this explains how they do it In a simple way pharmacodynamics studies the action of drugs the effects of drugs in terms of their biochemical and physiological effects and how the effects are generated
Why AI Is Changing What Good Validation Looks Like
The comprehensive landmark report and framework set out seven principles for using AI safely in pharmacovigilance together advocating a riskbased approach to governance validation and more Here ArisGlobals Jason Bryant highlights some of the guidances main assumptions as recently distilled in a podcast with Denny Lorenz a core member of the CIOMS XIV working group
-
Techno Trends
University of Dundee’s Cabamiquine Shows Promise for Single-Dose Malaria Treatment
Researchers at the University of Dundee have reported encouraging clinical results for cabamiquine a novel antimalarial compound being developed as a potential singledose treatment for malaria
-
Projects
Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility
Genentech a member of the Roche Group plans to invest approximately US million in a new device fillfinish manufacturing facility at its acre campus in Hillsboro Oregon The project will add endtoend manufacturing
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Market Access Strategies for Pharma Products in Europe: A Comprehensive Guide
Kate Williamson
This comprehensive guide provides pharmaceutical companies with strategic insights for navigating the diverse European market. Focusing on reimbursement, pricing, and market entry challenges, it empha...
-
2
Robotic Process Automation: The Catalyst for Pharma 4.0 Evolution
Kate Williamson
Robotic Process Automation (RPA) is essential in the Pharma 4.0 evolution, varying the pharmaceutical industry by automating repetitive tasks, reducing human errors, and enhancing efficiency. RPA supp...
-
3
Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026
Kate Williamson
This article analyzes the ethical sourcing in pharma and what should be the most optimal measures to establish sustainable transparent and ESG-focused supply chains by 2026. It explores the concept of...
-
4
Understanding Pharmacodynamics: The Science behind Drug Action Mechanisms
Kate Williamson
This article has examined the pharmacodynamics science, including drug action mechanisms, receptor theory, and determinants affecting drug efficacy and potency. It focuses on the importance of agonist...
-
5
Why AI Is Changing What Good Validation Looks Like
Jason Bryant
As AI becomes embedded in everyday pharmacovigilance, validation is only the starting point. This article examines how CIOMS XIV reframes responsible AI around continuous monitoring, proportionate ove...
press releases Read more...
PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia
PannTheraPi a clinicalstage biopharmaceutical company developing innovative treatments for neurological diseases by selectively targeting the pannexin Panx channel today announces approval by the French
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ...
Bristol Myers Squibb NYSE BMY today announced positive Phase results from the registrational QUINTESSENTIAL trial NCT of arlocabtagene autoleucel arlocel BMS in adult patients
Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)
Ionis Pharmaceuticals Inc Nasdaq IONS partner Novartis today announced that the pelacarsen Phase LpaHORIZON study a pioneering cardiovascular outcomes trial did not meet its primary endpoint
Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)
Novartis today announced that the pelacarsen phase III LpaHORIZON trial a pioneering cardiovascular outcomes study did not meet its primary endpoint of reducing the risk of cardiovascular events a composite
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWS Read more...
HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006
HCW Biologics Inc a USbased clinicalstage biopharmaceutical company has entered into an exclusive distribution agreement with Akron Biotech to commercialise HCW as a reagent for producing highly functional human CART cells
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology
AtomVie opens new radiopharmaceutical manufacturing facility in Ontario
AtomVie Global Radiopharma AtomVie has opened a new purposebuilt radiopharmaceutical manufacturing facility in Hamilton Ontario strengthening its capacity to support drug development and commercial production
Acepodia receives FDA clearance for ACE723 antibody-drug conjugate
Acepodia a clinicalstage biotechnology company developing cell therapies and antibodydrug conjugates ADCs has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ACE
Kali Therapeutics Receives U.S. FDA Clearance for KT501 Clinical Trial
Kali Therapeutics a clinicalstage biotechnology company developing immuneresetting and multispecific therapies has received clearance from the US Food and Drug Administration FDA for its Investigational New
Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development
Genedata has expanded its collaboration with Abcam to strengthen antibody development and support the use of artificial intelligence AI across Abcams global research and development operations








